Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

81
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
81
The Representativeness Heuristic02:13

The Representativeness Heuristic

15.9K
The representative heuristic describes a biased way of thinking, in which you unintentionally stereotype someone or something. For example, you may assume that your professors spend their free time reading books and engaging in intellectual conversation, because the idea of them spending their time playing volleyball or visiting an amusement park does not fit in with your stereotypes of professors.
15.9K
Polygenic Traits01:18

Polygenic Traits

66.1K
When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
66.1K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

101
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
101
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

115
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
115
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

832
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
832

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PDA (Privacy-Preserving Distributed Algorithms) in action: ten principles for high-quality multi-site clinical evidence generation.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

Promoting Problem-Solving Among Low-Income Adults With Type 2 Diabetes: Cluster-Randomized Controlled Trial of a Mobile Health Intervention With SMS Text Messaging (Mobile Diabetes Detective).

Journal of medical Internet research·2026
Same author

Real-world performance of large-scale propensity score adjustment strategies: Matching, weighting, and stratification.

Research square·2026
Same author

A comparison of Fast Healthcare Interoperability Resources and Observational Medical Mutcomes Partnership electronic health record data within the All of Us Research Program.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

The Effect of 4:3 Intermittent Fasting on Weight Loss at 12 Months.

Annals of internal medicine·2026
Same author

Heterogeneity of Treatment Effects Across Nine Glucose-Lowering Drug Classes in Type 2 Diabetes: Extension of the LEGEND-T2DM Network Study.

Diabetes, obesity & metabolism·2026

Related Experiment Video

Updated: Jul 31, 2025

Behavioral Phenotyping of Murine Disease Models with the Integrated Behavioral Station INBEST
12:18

Behavioral Phenotyping of Murine Disease Models with the Integrated Behavioral Station INBEST

Published on: April 23, 2015

10.0K

Characterizing Patient Representations for Computational Phenotyping.

Tiffany J Callahan1,2, Adrianne L Stefanksi2, Danielle M Ostendorf2

  • 1Columbia University, New York, NY, 10032, USA.

AMIA ... Annual Symposium Proceedings. AMIA Symposium
|May 2, 2023
PubMed
Summary

Patient representation learning for computational phenotypes (CP) requires careful data selection. Data type and sampling windows significantly impact rare disease classification performance, highlighting the need for data-driven characterization.

More Related Videos

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.6K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

20.8K

Related Experiment Videos

Last Updated: Jul 31, 2025

Behavioral Phenotyping of Murine Disease Models with the Integrated Behavioral Station INBEST
12:18

Behavioral Phenotyping of Murine Disease Models with the Integrated Behavioral Station INBEST

Published on: April 23, 2015

10.0K
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.6K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

20.8K

Area of Science:

  • Medical Informatics
  • Machine Learning in Healthcare
  • Computational Biology

Background:

  • Patient representation learning methods offer rich data representations for advancing computational phenotypes (CP).
  • Current methods are limited by using predefined concept sets or all patient data, hindering novel discovery and explainability.
  • Developing data-driven approaches is crucial for optimizing CP development.

Purpose of the Study:

  • To extensively characterize the utility of patient representation learning for computational phenotype development.
  • To investigate the impact of different data types and sampling windows on rare disease classification using patient representations.
  • To provide a data-driven foundation for patient representation-based CP development pipelines.

Main Methods:

  • Conducted ablation studies on patient representation learning methods.
  • Varied combinations of data types and sampling windows were used to build patient representations.
  • Evaluated the impact of these representations on rare disease classification and clustering performance.

Main Results:

  • Patient representation learning performance is directly impacted by the choice of data type and sampling window.
  • Classification and clustering performance varied significantly across different rare disease groups.
  • Preliminary results underscore the importance of data-driven characterization in CP development.

Conclusions:

  • The selection of data types and sampling windows is critical for effective patient representation learning in CP development.
  • A data-driven approach is essential for optimizing the performance and explainability of computational phenotypes.
  • Further research is needed to refine these methods for diverse rare diseases.